Physician profile
Fritz Baumgartner
NPI 1134237761
$5,923.73
in general payments reported to CMS, 2019-2025
19 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $1,361 · 2021: $3,818 · 2022: $162 · 2023: $71.67 · 2024: $197 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,692.33 | 2021-2024 | Venclose Maven Catheter |
| Aesculap, INC. | $1,340.60 | 2020 | |
| Integra Lifesciences Corporation | $136.93 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| W. L. Gore & Associates, INC. | $124.84 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Baxter Healthcare | $94.03 | 2024-2025 | Floseal, Perclot |
| Innocoll Pharmaceuticals Limited | $83.07 | 2021 | |
| Urgo Medical North America, LLC | $75.44 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Biotissue Holdings INC. | $63.71 | 2021-2022 | |
| Ethicon US, LLC | $57.29 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $55.25 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $34.78 | 2022 | |
| Lemaitre Vascular, INC. | $29.08 | 2019 | |
| Boston Scientific Corporation | $23.34 | 2025 | Enroute Transcarotid Neuroprotection System |
| Inspiremd LTD | $22.66 | 2025 | Cguard Prime Carotid Stent System |
| Kls-Martin L.P. | $21.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $21.29 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Biocompatibles, INC. | $17.22 | 2019 | |
| Solventum Corporation | $16.34 | 2024 | Prevena |
| Mimedx Group, INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fritz Baumgartner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.